News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026February 19, 2026 Epsilon Healthcare has established a new subsidiary, Epsilon Biotech, which the firm said would accelerate its […]
Epsilon posts strongest December quarter following ASX reinstatement by Adam Sheldon January 28, 2026January 28, 2026
Epsilon Healthcare resumes trading on ASX after two-year suspension by Steve Jones December 19, 2025December 22, 2025
Epsilon and former chairman told to mediate in bid to settle dispute by Steve Jones December 15, 2025December 16, 2025
Epsilon working with ASX as two-year suspension deadline approaches by Adam Sheldon December 9, 2025December 10, 2025
Epsilon’s record quarter evidence of ‘remarkable turnaround’, says CEO by Steve Jones November 8, 2025November 8, 2025
News in brief: Epsilon receives EU, UK GMP certificates; AGH raises $2.6m via placement; Zelira secures loan notes; Bioxyne’s $5m German order by Steve Jones September 17, 2025February 21, 2026
News in brief: Wragg joins ANTG; Bioxyne launches legal claim; Epsilon appoints Kaplon by Martin Lane August 28, 2025February 21, 2026
News in brief: Shahin becomes Vitura’s largest shareholder; Avecho progresses CBD insomnia trial; Epsilon reports improved cashflow; Zelira locks in R&D loan to advance trial by Adam Sheldon July 31, 2025July 31, 2025
Epsilon reduces debt through sale and leaseback of Southport facility by Steve Jones July 29, 2025July 29, 2025
